PINK1 and LRRK2 with associated protein kinase B (AKT) and c-Jun N-terminal kinase (JNK) signaling pathways have proven to be strong footings in PD (Mehdi et al., 2016). This evidence concerns the gene LRRK2 and Parkinson disease.